Comparison of two commercial multiplex PCR assays for the detection of sexually transmitted infections
Introduction: Multiplex molecular panels are replacing conventional methods for the detection of sexually transmitted infections. In the current study, we evaluated the performance of two commercial multiplex assays, EUROArray STI and Allplex STI essential assays, for detecting six sexually transmit...
Saved in:
Published in | Journal of infection in developing countries Vol. 16; no. 2; pp. 333 - 338 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Italy
Journal of Infection in Developing Countries
28.02.2022
The Journal of Infection in Developing Countries |
Subjects | |
Online Access | Get full text |
ISSN | 1972-2680 2036-6590 1972-2680 |
DOI | 10.3855/jidc.15279 |
Cover
Loading…
Abstract | Introduction: Multiplex molecular panels are replacing conventional methods for the detection of sexually transmitted infections. In the current study, we evaluated the performance of two commercial multiplex assays, EUROArray STI and Allplex STI essential assays, for detecting six sexually transmitted infections.
Methodology: The diagnostic performance of the EUROArray STI and Allplex STI essential assays was evaluated against a panel of 105 positive DNA samples identified by in-house real-time PCR assays including Ureaplasma parvum, Ureaplasma urealyticum, Mycoplasma hominis, Trichomonas vaginalis, Chlamydia trachomatis, and Neisseria gonorrhea. Samples from healthy subjects, negative for any microorganism, were used as negative controls.
Results: Of the 105 positive specimens, 103 (98%) were tested positive by Allplex and 102 (97%) by EUROArray. Among the 51 negative samples that were tested by in house assay, 48 (94%) were tested negative by Allplex assay and 43 (84%) by EUROArray assay. The overall sensitivity of EUROArray and Allplex were 97.1% and 98.1% with an accuracy of 92.9% and 96.7%, respectively. The overall assay specificity was 94.1% for Allplex assay and 84.3% for EUROArray assay, The sensitivity of both kits to all targeted microorganisms ranged from 55.6% to 100%, with the lowest sensitivity noted for Trichomonas vaginalis.
Conclusions: Diagnostic performance varies depending on the method used to detect the targeted pathogens, the assay manipulation, and the cost. This study showed sensitivity, specificity, and accuracy characteristics for two kits commonly used to detect STIs, which will guide the choice for an appropriate multiplex PCR platform. |
---|---|
AbstractList | Multiplex molecular panels are replacing conventional methods for the detection of sexually transmitted infections. In the current study, we evaluated the performance of two commercial multiplex assays, EUROArray STI and Allplex STI essential assays, for detecting six sexually transmitted infections.
The diagnostic performance of the EUROArray STI and Allplex STI essential assays was evaluated against a panel of 105 positive DNA samples identified by in-house real-time PCR assays including Ureaplasma parvum, Ureaplasma urealyticum, Mycoplasma hominis, Trichomonas vaginalis, Chlamydia trachomatis, and Neisseria gonorrhea. Samples from healthy subjects, negative for any microorganism, were used as negative controls.
Of the 105 positive specimens, 103 (98%) were tested positive by Allplex and 102 (97%) by EUROArray. Among the 51 negative samples that were tested by in house assay, 48 (94%) were tested negative by Allplex assay and 43 (84%) by EUROArray assay. The overall sensitivity of EUROArray and Allplex were 97.1% and 98.1% with an accuracy of 92.9% and 96.7%, respectively. The overall assay specificity was 94.1% for Allplex assay and 84.3% for EUROArray assay, The sensitivity of both kits to all targeted microorganisms ranged from 55.6% to 100%, with the lowest sensitivity noted for Trichomonas vaginalis.
Diagnostic performance varies depending on the method used to detect the targeted pathogens, the assay manipulation, and the cost. This study showed sensitivity, specificity, and accuracy characteristics for two kits commonly used to detect STIs, which will guide the choice for an appropriate multiplex PCR platform. Introduction: Multiplex molecular panels are replacing conventional methods for the detection of sexually transmitted infections. In the current study, we evaluated the performance of two commercial multiplex assays, EUROArray STI and Allplex STI essential assays, for detecting six sexually transmitted infections. Methodology: The diagnostic performance of the EUROArray STI and Allplex STI essential assays was evaluated against a panel of 105 positive DNA samples identified by in-house real-time PCR assays including Ureaplasma parvum, Ureaplasma urealyticum, Mycoplasma hominis, Trichomonas vaginalis, Chlamydia trachomatis, and Neisseria gonorrhea. Samples from healthy subjects, negative for any microorganism, were used as negative controls. Results: Of the 105 positive specimens, 103 (98%) were tested positive by Allplex and 102 (97%) by EUROArray. Among the 51 negative samples that were tested by in house assay, 48 (94%) were tested negative by Allplex assay and 43 (84%) by EUROArray assay. The overall sensitivity of EUROArray and Allplex were 97.1% and 98.1% with an accuracy of 92.9% and 96.7%, respectively. The overall assay specificity was 94.1% for Allplex assay and 84.3% for EUROArray assay, The sensitivity of both kits to all targeted microorganisms ranged from 55.6% to 100%, with the lowest sensitivity noted for Trichomonas vaginalis. Conclusions: Diagnostic performance varies depending on the method used to detect the targeted pathogens, the assay manipulation, and the cost. This study showed sensitivity, specificity, and accuracy characteristics for two kits commonly used to detect STIs, which will guide the choice for an appropriate multiplex PCR platform. Introduction: Multiplex molecular panels are replacing conventional methods for the detection of sexually transmitted infections. In the current study, we evaluated the performance of two commercial multiplex assays, EUROArray STI and Allplex STI essential assays, for detecting six sexually transmitted infections. Methodology: The diagnostic performance of the EUROArray STI and Allplex STI essential assays was evaluated against a panel of 105 positive DNA samples identified by in-house real-time PCR assays including Ureaplasma parvum, Ureaplasma urealyticum, Mycoplasma hominis, Trichomonas vaginalis, Chlamydia trachomatis, and Neisseria gonorrhea. Samples from healthy subjects, negative for any microorganism, were used as negative controls. Results: Of the 105 positive specimens, 103 (98%) were tested positive by Allplex and 102 (97%) by EUROArray. Among the 51 negative samples that were tested by in house assay, 48 (94%) were tested negative by Allplex assay and 43 (84%) by EUROArray assay. The overall sensitivity of EUROArray and Allplex were 97.1% and 98.1% with an accuracy of 92.9% and 96.7%, respectively. The overall assay specificity was 94.1% for Allplex assay and 84.3% for EUROArray assay, The sensitivity of both kits to all targeted microorganisms ranged from 55.6% to 100%, with the lowest sensitivity noted for Trichomonas vaginalis. Conclusions: Diagnostic performance varies depending on the method used to detect the targeted pathogens, the assay manipulation, and the cost. This study showed sensitivity, specificity, and accuracy characteristics for two kits commonly used to detect STIs, which will guide the choice for an appropriate multiplex PCR platform. Multiplex molecular panels are replacing conventional methods for the detection of sexually transmitted infections. In the current study, we evaluated the performance of two commercial multiplex assays, EUROArray STI and Allplex STI essential assays, for detecting six sexually transmitted infections.INTRODUCTIONMultiplex molecular panels are replacing conventional methods for the detection of sexually transmitted infections. In the current study, we evaluated the performance of two commercial multiplex assays, EUROArray STI and Allplex STI essential assays, for detecting six sexually transmitted infections.The diagnostic performance of the EUROArray STI and Allplex STI essential assays was evaluated against a panel of 105 positive DNA samples identified by in-house real-time PCR assays including Ureaplasma parvum, Ureaplasma urealyticum, Mycoplasma hominis, Trichomonas vaginalis, Chlamydia trachomatis, and Neisseria gonorrhea. Samples from healthy subjects, negative for any microorganism, were used as negative controls.METHODOLOGYThe diagnostic performance of the EUROArray STI and Allplex STI essential assays was evaluated against a panel of 105 positive DNA samples identified by in-house real-time PCR assays including Ureaplasma parvum, Ureaplasma urealyticum, Mycoplasma hominis, Trichomonas vaginalis, Chlamydia trachomatis, and Neisseria gonorrhea. Samples from healthy subjects, negative for any microorganism, were used as negative controls.Of the 105 positive specimens, 103 (98%) were tested positive by Allplex and 102 (97%) by EUROArray. Among the 51 negative samples that were tested by in house assay, 48 (94%) were tested negative by Allplex assay and 43 (84%) by EUROArray assay. The overall sensitivity of EUROArray and Allplex were 97.1% and 98.1% with an accuracy of 92.9% and 96.7%, respectively. The overall assay specificity was 94.1% for Allplex assay and 84.3% for EUROArray assay, The sensitivity of both kits to all targeted microorganisms ranged from 55.6% to 100%, with the lowest sensitivity noted for Trichomonas vaginalis.RESULTSOf the 105 positive specimens, 103 (98%) were tested positive by Allplex and 102 (97%) by EUROArray. Among the 51 negative samples that were tested by in house assay, 48 (94%) were tested negative by Allplex assay and 43 (84%) by EUROArray assay. The overall sensitivity of EUROArray and Allplex were 97.1% and 98.1% with an accuracy of 92.9% and 96.7%, respectively. The overall assay specificity was 94.1% for Allplex assay and 84.3% for EUROArray assay, The sensitivity of both kits to all targeted microorganisms ranged from 55.6% to 100%, with the lowest sensitivity noted for Trichomonas vaginalis.Diagnostic performance varies depending on the method used to detect the targeted pathogens, the assay manipulation, and the cost. This study showed sensitivity, specificity, and accuracy characteristics for two kits commonly used to detect STIs, which will guide the choice for an appropriate multiplex PCR platform.CONCLUSIONSDiagnostic performance varies depending on the method used to detect the targeted pathogens, the assay manipulation, and the cost. This study showed sensitivity, specificity, and accuracy characteristics for two kits commonly used to detect STIs, which will guide the choice for an appropriate multiplex PCR platform. |
Author | El Bikai, Rana El Chaar, Mira Hanna, Jessica Mohtar, Jad Yassin, Ruba |
Author_xml | – sequence: 1 givenname: Ruba surname: Yassin fullname: Yassin, Ruba – sequence: 2 givenname: Jessica surname: Hanna fullname: Hanna, Jessica – sequence: 3 givenname: Rana surname: El Bikai fullname: El Bikai, Rana – sequence: 4 givenname: Jad surname: Mohtar fullname: Mohtar, Jad – sequence: 5 givenname: Mira surname: El Chaar fullname: El Chaar, Mira |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35298429$$D View this record in MEDLINE/PubMed |
BookMark | eNptkU2LFDEQhoOsuB968QdIwIsIsybppDs5yuDHwoIieg41SUUzpDtjkmZ3_r09O-sii4dQITz1UqnnnJxMeUJCXnJ22Wml3m2jd5dcicE8IWfcDGIles1O_rmfkvNat4wp0yn-jJx2ShgthTkjYZ3HHZRY80RzoO0mU5fHEYuLkOg4pxZ3CW_p1_U3CrXCvtKQC22_kHps6Fo8Nla8nSGlPW0FpjrG1tDTOIUjUZ-TpwFSxRf39YL8-Pjh-_rz6vrLp6v1--uVk3xoKwSBPde6Y1IHCRCUdqC8cNKj59op3Q9DvxzvpdhwvhGDAgO-90wi20B3Qa6OuT7D1u5KHKHsbYZo7x5y-WmhtOgSWvSB88FwLZiXA9OAQhnGveTOOAlhyXpzzNqV_HvG2uwYq8OUYMI8Vyt6yRljpmcL-voRus1zmZaf2o53_DCz6Rbq1T01b0b0D-P9tbEAb4-AK7nWguEB4cweVNuDanuneoHZI9jFBodtLwpi-l_LH90IrD4 |
CitedBy_id | crossref_primary_10_1099_jmm_0_001797 crossref_primary_10_1038_s41598_023_38121_w crossref_primary_10_1021_acsomega_4c04385 crossref_primary_10_1093_cid_ciad508 crossref_primary_10_3389_fmed_2024_1328589 |
ContentType | Journal Article |
Copyright | Copyright (c) 2022 Ruba Yassin, Jessica Hanna, Rana El Bikai, Jad Mohtar, Mira El Chaar. 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: Copyright (c) 2022 Ruba Yassin, Jessica Hanna, Rana El Bikai, Jad Mohtar, Mira El Chaar. – notice: 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 8C1 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 DOA |
DOI | 10.3855/jidc.15279 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Public Health Database ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Public Health ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Central Health Research Premium Collection ProQuest One Academic UKI Edition ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) MEDLINE - Academic |
DatabaseTitleList | MEDLINE Publicly Available Content Database CrossRef MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Public Health |
EISSN | 1972-2680 |
EndPage | 338 |
ExternalDocumentID | oai_doaj_org_article_edf11791820d4708ae25901d41c9c4af 35298429 10_3855_jidc_15279 |
Genre | Journal Article |
GroupedDBID | --- 29K 2WC 53G 5GY 8C1 AAYXX ABDBF ABUWG ACGFO ACUHS ADBBV AEGXH AENEX AFKRA AIAGR ALIPV ALMA_UNASSIGNED_HOLDINGS BAWUL BCNDV BENPR CCPQU CITATION CS3 D-I DIK E3Z EBD ECGQY EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 KWQ OK1 OVT PHGZM PHGZT PIMPY RNS SV3 TR2 TUS UKHRP ~8M CGR CUY CVF ECM EIF NPM AZQEC DWQXO PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 PUEGO |
ID | FETCH-LOGICAL-c417t-ea2e61883048f4aaf58ca5d2c4ded18c586776677dd42b11b275a9ad6d04e0ba3 |
IEDL.DBID | DOA |
ISSN | 1972-2680 2036-6590 |
IngestDate | Wed Aug 27 01:28:46 EDT 2025 Thu Jul 10 22:47:30 EDT 2025 Fri Jul 25 23:39:18 EDT 2025 Thu Jan 02 22:55:30 EST 2025 Tue Jul 01 04:38:49 EDT 2025 Thu Apr 24 22:59:56 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | specificity STI sensitivity commercial assays |
Language | English |
License | https://creativecommons.org/licenses/by/4.0 Copyright (c) 2022 Ruba Yassin, Jessica Hanna, Rana El Bikai, Jad Mohtar, Mira El Chaar. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c417t-ea2e61883048f4aaf58ca5d2c4ded18c586776677dd42b11b275a9ad6d04e0ba3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://doaj.org/article/edf11791820d4708ae25901d41c9c4af |
PMID | 35298429 |
PQID | 3131776693 |
PQPubID | 5199004 |
PageCount | 6 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_edf11791820d4708ae25901d41c9c4af proquest_miscellaneous_2641000960 proquest_journals_3131776693 pubmed_primary_35298429 crossref_primary_10_3855_jidc_15279 crossref_citationtrail_10_3855_jidc_15279 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-02-28 |
PublicationDateYYYYMMDD | 2022-02-28 |
PublicationDate_xml | – month: 02 year: 2022 text: 2022-02-28 day: 28 |
PublicationDecade | 2020 |
PublicationPlace | Italy |
PublicationPlace_xml | – name: Italy – name: Sassari |
PublicationTitle | Journal of infection in developing countries |
PublicationTitleAlternate | J Infect Dev Ctries |
PublicationYear | 2022 |
Publisher | Journal of Infection in Developing Countries The Journal of Infection in Developing Countries |
Publisher_xml | – name: Journal of Infection in Developing Countries – name: The Journal of Infection in Developing Countries |
SSID | ssj0059351 |
Score | 2.288997 |
Snippet | Introduction: Multiplex molecular panels are replacing conventional methods for the detection of sexually transmitted infections. In the current study, we... Multiplex molecular panels are replacing conventional methods for the detection of sexually transmitted infections. In the current study, we evaluated the... |
SourceID | doaj proquest pubmed crossref |
SourceType | Open Website Aggregation Database Index Database Enrichment Source |
StartPage | 333 |
SubjectTerms | Chlamydia trachomatis - genetics commercial assays Humans Infections Multiplex Polymerase Chain Reaction - methods sensitivity Sensitivity and Specificity Sexually transmitted diseases Sexually Transmitted Diseases - diagnosis specificity STD STI Trichomonas vaginalis - genetics |
SummonAdditionalLinks | – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3LT98wDI42uEya0N7rYFOm7bJDRdM8mp4m-AmEJg0hNCRuVV6dQNAyWsT477HTtOOw7dBLm1RtEtufE_szIZ8ZC66qNIcZUCYXldG5LYTJjeNcWKVCG5PEvh-qgxPx7VSepg23IYVVzjoxKmrfO9wj3-YMLF2lVM2_Xv3KsWoUnq6mEhqPyTqoYA3O1_ru3uHR8ayLZc1jAUY8bcuVrIuJoJRrKbfPz7zD6j8YxPXAJEXm_n_DzWh29p-RjYQX6c40wc_Jo9C9IE-nzTY65RC9JO1qqSZI-5aOtz2Fn7rEYkrQd44Z_E2PVscUwLK5GyhgVQrYj_owxmCs2HGI_MsXd3REC3Z5NgIcpXO4Vje8Iif7ez9WB3kqoJA7waoxD6YMimnNQUxbYUwrtTPSl0744Jl2EsnsFFzei9IyZstKmtp45QsRCmv4a7LW9V14SyiPrD7G-joIUbraWgmvq50Df4VVXGTkyzyGjUvs4ljk4qIBLwPHu8HxbuJ4Z-TT0vZq4tT4a6tdnIqlBfJgxxv99c8miVUTfIucdshC70VVaBNKTKb1grnaCdNmZGueyCYJ59D8WUoZ-bg8BrHCsxLThf5maAAnssm_y8ibaQEsXwKYtdZgx9_9_-Wb5EmJuRIx_32LrI3XN-E9IJjRfkjL9B7IKfDe priority: 102 providerName: ProQuest |
Title | Comparison of two commercial multiplex PCR assays for the detection of sexually transmitted infections |
URI | https://www.ncbi.nlm.nih.gov/pubmed/35298429 https://www.proquest.com/docview/3131776693 https://www.proquest.com/docview/2641000960 https://doaj.org/article/edf11791820d4708ae25901d41c9c4af |
Volume | 16 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Nb9UwDLdgXJAQ4pvCeAqCC4dqL03Spkf2tGlCYpomJu0W5avS0NY30U6w_x47aasdQFw49NImVeo48c-p_TPAR86jbxotcAZqW8rG6tKtpS2tF0K6uo5dShL7elwfnckv5-r8TqkvignL9MBZcHsxdMRaRjzjQTZrbWNF6ZJBct96aTvafdHmzc5U3oNVKxTPZKRCK7X3_SJ4qvRDAVt3zE9i6f87tEwm5vAJPJ6wIfucx_QU7sX-GTzKB2ss5ws9h26zVA5k246NP7cMleaKCidh3zk-8Bc72ZwyBMb2dmCISxniPBbimAKvUschcS1f3rKRrNXVxYjQk82hWf3wAs4OD75tjsqpWELpJW_GMtoq1lxrgUuyk9Z2SnurQuVliIFrr4i4rsYrBFk5zl3VKNvaUIe1jGtnxUvY6bd9fA1MJAYf60Ibpax865zC17Xeo2_CGyEL-DTL0PiJSZwKWlwa9ChI3obkbZK8C_iwtL3O_Bl_bLVPU7G0IM7rdAM1wUyaYP6lCQXszhNppoU4GMERIOF3t6KA98tjXEL0X8T2cXszGMSEPPtyBbzKCrCMBPFpq9Fmv_kfI3wLDyvKnkgZ8buwM_64ie8Q04xuBff1hq_gwf7B8cnpKinzb5DQ-Cs |
linkProvider | Directory of Open Access Journals |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Nb9QwEB2V7QEkhPgmUMAIOHCIGseO4xwQokurLW1XVdVKvRnHdlBRm5QmVdk_xW9k7CQLB-DWQy6JY0Xjsf0mnnkP4A2lzuS5ZDgCQsc81zIuE65jbRjjpRCuCkVie3MxO-Kfj7PjFfg51sL4tMpxTQwLtW2M_0e-zijudLkQBftw_j32qlH-dHWU0OjdYsctrjBka99vf8LxfZumW5uH01k8qArEhtO8i51OnaBSYhwvK651lUmjM5sabp2l0mSe4U3gZS1PS0rLNM90oa2wCXdJqRn2ewNWOcNQZgKrG5vz_YNx7c8KFgQf_eleLLIi6QlRmcyy9W8n1ni1IZ809scWGJQC_g1vwza3dRfuDPiUfOwd6h6suPo-3O5_7pG-ZukBVNOleiFpKtJdNQSNeObFm_DdMUfxB9mfHhAE53rREsTGBLEmsa4LyV_hxTbwPZ8uSOd3zLOTDuEvGdPD6vYhHF2LaR_BpG5q9wQICyxCurSF4zw1RVlm2F1hDMZHNGc8gnejDZUZ2My9qMapwqjG21t5e6tg7wheL9ue9xwef2214Ydi2cLzbocbzcVXNUxj5WzlOfQ8673leSK1S33xruXUFIbrKoK1cSDVsBi06rfrRvBq-RinsT-b0bVrLluFuJT28WQEj3sHWH4JYuRCIm54-v_OX8LN2eHertrdnu88g1upr9MItfdrMOkuLt1zRE9d-WJwWQJfrnuW_AL6By5M |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comparison+of+two+commercial+multiplex+PCR+assays+for+the+detection+of+sexually+transmitted+infections&rft.jtitle=Journal+of+infection+in+developing+countries&rft.au=Ruba+Yassin&rft.au=Jessica+Hanna&rft.au=Rana+El+Bikai&rft.au=Jad+Mohtar&rft.date=2022-02-28&rft.pub=The+Journal+of+Infection+in+Developing+Countries&rft.eissn=1972-2680&rft.volume=16&rft.issue=2&rft_id=info:doi/10.3855%2Fjidc.15279&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_edf11791820d4708ae25901d41c9c4af |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1972-2680&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1972-2680&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1972-2680&client=summon |